Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE

Mid Cap | Pharmaceuticals & Drugs

942.55

3.35 (0.36%)

< Home < Back

Zydus Lifesciences Ltd. News

>>

Zydus Lifesciences informs about press release

>>

Zydus Lifesciences gets EIR for Baddi facility from USFDA

>>

Zydus Lifesciences gains on getting NoC for generic Mesalamine suppositories 1000 mg

>>

Zydus Lifesciences gets NoC for generic Mesalamine suppositories 1000 mg

>>

Zydus Lifesciences’ arm acquires balance share capital in Amplitude Surgical SA

>>

Zydus Lifesciences informs about certificate

>>

Zydus Lifesciences trades higher on the BSE

>>

Zydus Lifesciences’ arm recalls over 1,500 boxes of antiviral medication

>>

Zydus Lifesciences gets NoC for generic Liothyronine tablets 5 mcg, 25 mcg

>>

Zydus Lifesciences gets USFDA’s final approval for Deflazacort oral suspension

<< < 8 9 10 ...168 > >>